Semaglutide does activate GLP-1 receptors in brain regions that regulate mood and stress response, making direct causation plausible in some patients
decreased smooth muscle cell proliferation reduces neointimal formation Anti-inflammatory signaling: Suppression of NF-kB, reduced macrophage infiltration into plaques, and decreased secretion of IL-6, TNF-alpha, and MCP-1 from monocytes and foam cells Atherogenic lipid reduction: Improvements in LDL cholesterol, VLDL, triglycerides, and chylomicron remnants beyond what weight loss alone would predict Blood pressure reduction: Through direct vasodilation and natriuresis, independent of weight change Epicardial and perivascular fat reduction: This fat depot exerts direct paracrine inflammatory effects on the vascular endothelium and myocardium
He graduated from his residency 60 pounds heavier in 2016
In a Phase 3 trial, orforglipron demonstrated a reduction in HbA1c levels by up to 1.6% and an average weight loss of 16 pounds over 40 weeks
By working with your body to naturally reduce appetite and improve metabolic function, Semaglutide supports steady, sustainable weight loss without extreme diets or surgery
Dose increases occur gradually, which helps maintain side effects low and gradually reduces hunger or cravings